We will be identifying clinical sites for a clinical trial under FDA’s Investigational Device Exemption (IDE) regulations.  We seek to include a select group of 20 spine surgeons and interventional radiologists, distributed across the U.S., to conduct this study.  In choosing clinical sites, the company will give preference to those that have a large number of patients receiving steroid injections and experience with IDE trials or publishing research.  Clinical sites should have a dedicated research staff to ensure that the protocol is strictly followed.

The study will be a randomized trial but the control group has not yet been determined. The study will commence when preclinical work is complete.

Contact us if you would like to be considered as a clinical site.